Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Study ID: NCT06827639
Start Date: 2025-04-30
End Date: 2028-04-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

640

Intervention / Treatment

blood collection

tissue specimen collection

Sponsor

Public assistance Hospitals in Marseille

Source: clinicaltrials.gov

Share:
Add to list

QL1706 Combined with Lenvatinib and GEMOX As First - Line Treatment for Unresectable Biliary Tract Tumors

Study ID: NCT06892925
Start Date: 2025-05
End Date: 2029-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

59

Intervention / Treatment

QL1706

Sponsor

Eastern Hepatobiliary Surgery Hospital

Source: clinicaltrials.gov

Share:
Add to list

Effects and Mechanisms of RAS Training on Upper-limb Movements in PD Patients

Study ID: NCT05782322
Start Date: 2025-05-01
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

Upper-limb training involving RAS

Upper-limb training without the aid of RAS

Sponsor

The Hong Kong Polytechnic University

Source: clinicaltrials.gov

Share:
Add to list

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

Study ID: NCT06927739
Start Date: 2025-06-15
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

240

Intervention / Treatment

Icticumab

Placebo

Sponsor

Abcentra

Source: clinicaltrials.gov

Share:
Add to list

Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion

Study ID: NCT06916325
Start Date: 2025-07
End Date: 2032-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

215

Intervention / Treatment

dual hypothermic oxygenated perfusion (DHOPE)

Sponsor

XVIVO Perfusion

Source: clinicaltrials.gov

Share:
Add to list

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

Study ID: NCT06855225
Start Date: 2025-06
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

29

Intervention / Treatment

Tremelimumab

Durvalumab

Gemcitabine

Cisplatin

Sponsor

Mehmet action

Source: clinicaltrials.gov

Share:
Add to list

Effects of Mat and Reformer Pilates in Multiple Sclerosis

Study ID: NCT06931522
Start Date: 2025-05-01
End Date: 2025-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Mat Pilates

Reformer Pilates

Sponsor

Gazi University

Source: clinicaltrials.gov

Share:
Add to list

Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.

Study ID: NCT06694025
Start Date: 2025-10-01
End Date: 2030-12-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

670

Intervention / Treatment

Efluelda Tetra Pre-filled syringe

Sponsor

Sanofi

Source: clinicaltrials.gov

Share:
Add to list

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

Study ID: NCT06614322
Start Date: 2025-09
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

190

Intervention / Treatment

Pregabalin

Duloxetine

Placebo

Sponsor

University of Rochester

Source: clinicaltrials.gov

Share:
Add to list

Get Social Media and Risk-Reduction Training

Study ID: NCT06618586
Start Date: 2025-05
End Date: 2028-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment

TodaysBaby

Sponsor

University of Virginia

Source: clinicaltrials.gov

Share:
Add to list